Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics - Product Thumbnail Image

Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics

  • Report
  • 183 Pages
From
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence - Product Thumbnail Image

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • Report
  • 170 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
T-Cell Immunotherapy Market (3rd Edition), 2018-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (3rd Edition), 2018-2030

  • Report
  • 850 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Global Breast Cancer Monoclonal Antibodies Market 2016-2020 - Product Thumbnail Image

Global Breast Cancer Monoclonal Antibodies Market 2016-2020

  • Report
  • 88 Pages
From
CAR-T Therapies Market, 2018-2030 - Product Thumbnail Image

CAR-T Therapies Market, 2018-2030

  • Report
  • 548 Pages
From
Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors - Product Thumbnail Image

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

  • Report
  • 420 Pages
From
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 3085 Pages
From
Breast Cancer Diagnostic and Drug Technologies: Global Markets - Product Thumbnail Image

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • Report
  • 154 Pages
From
Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 127 Pages
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 853 Pages
From
Gastric Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Gastric Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1283 Pages
From
Esophageal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Esophageal Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 639 Pages
From
Global Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025 - Product Thumbnail Image

Global Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • Report
From
Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 120 Pages
From
Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022

  • Report
  • 157 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • 215 Pages
From
Loading Indicator
adroll